心房颤动患者的体重指数、生活质量与导管消融术
Body Mass Index, Quality of Life, and Catheter Ablation in Patients with Atrial Fibrillation.
作者信息
Ellis Ethan R, Reynolds Matthew R
机构信息
Beth Israel Deaconess Medical Center.
Harvard Clinical Research Institute, Boston, Massachusetts, USA.
出版信息
J Atr Fibrillation. 2012 Dec 16;5(4):426. doi: 10.4022/jafib.426. eCollection 2012 Dec.
Abstract
Atrial fibrillation and obesity are interlinked epidemics and both impair quality of life. As the prevalence of both conditions in the US continues to rise, so will the number of obese patients with atrial fibrillation referred for catheter ablation. Catheter ablation has already been shown to significantly improve quality of life in patients with atrial fibrillation. Until recently, there has been little attention to the effects of catheter ablation on quality of life specifically in obese patients with atrial fibrillation. This paper will review what is known about the effects of atrial fibrillation and obesity on quality of life and how quality of life is affected by catheter ablation for atrial fibrillation in obese patients.
摘要
心房颤动和肥胖是相互关联的流行病，二者都会损害生活质量。随着这两种疾病在美国的患病率持续上升，转诊接受导管消融术的肥胖心房颤动患者数量也会增加。导管消融术已被证明能显著改善心房颤动患者的生活质量。直到最近，人们才开始关注导管消融术对生活质量的影响，尤其是对肥胖心房颤动患者生活质量的影响。本文将综述关于心房颤动和肥胖对生活质量的影响，以及导管消融术如何影响肥胖心房颤动患者生活质量的相关知识。
相似文献
1
Body Mass Index, Quality of Life, and Catheter Ablation in Patients with Atrial Fibrillation.心房颤动患者的体重指数、生活质量与导管消融术
J Atr Fibrillation. 2012 Dec 16;5(4):426. doi: 10.4022/jafib.426. eCollection 2012 Dec.
2
Catheter ablation for atrial fibrillation in patients with obesity.肥胖患者心房颤动的导管消融治疗
Circulation. 2008 May 20;117(20):2583-90. doi: 10.1161/CIRCULATIONAHA.107.716712. Epub 2008 May 12.
3
The Ablate and Pace Trial: a prospective study of catheter ablation of the AV conduction system and permanent pacemaker implantation for treatment of atrial fibrillation. APT Investigators.消融与起搏试验：一项关于房室传导系统导管消融及永久性起搏器植入治疗心房颤动的前瞻性研究。APT研究人员。
J Interv Card Electrophysiol. 1998 Jun;2(2):121-35. doi: 10.1023/a:1009795330454.
4
Outcomes of Atrial Fibrillation Ablation in Morbidly Obese Patients Following Bariatric Surgery Compared With a Nonobese Cohort.肥胖症患者行减重手术后与非肥胖患者行房颤消融术的结局比较。
Circ Arrhythm Electrophysiol. 2019 Oct;12(10):e007598. doi: 10.1161/CIRCEP.119.007598. Epub 2019 Oct 15.
5
A comparison of the real world effectiveness of catheter ablation and drug therapy in atrial fibrillation patients in a Chinese setting.中国背景下导管消融与药物治疗在房颤患者中的真实世界疗效比较。
BMC Cardiovasc Disord. 2017 Jul 27;17(1):204. doi: 10.1186/s12872-017-0634-y.
6
Effects of radiofrequency catheter ablation on quality of life in patients with atrial flutter.射频导管消融术对心房扑动患者生活质量的影响。
Am J Cardiol. 1999 Aug 1;84(3):278-83. doi: 10.1016/s0002-9149(99)00276-3.
7
Effect of Catheter Ablation vs Antiarrhythmic Medication on Quality of Life in Patients With Atrial Fibrillation: The CAPTAF Randomized Clinical Trial.导管消融与抗心律失常药物治疗对心房颤动患者生活质量的影响：CAPTAF 随机临床试验。
JAMA. 2019 Mar 19;321(11):1059-1068. doi: 10.1001/jama.2019.0335.
8
Influence of body mass index on quality of life in atrial fibrillation patients undergoing catheter ablation.体重指数对接受导管消融的心房颤动患者生活质量的影响。
Heart Rhythm. 2011 Dec;8(12):1847-52. doi: 10.1016/j.hrthm.2011.07.005. Epub 2011 Jul 6.
9
[Risk factors for atrial fibrillation recurrence after catheter ablation].[导管消融术后心房颤动复发的危险因素]
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2019 Oct 28;44(10):1196-1202. doi: 10.11817/j.issn.1672-7347.2019.190326.
10
A prospective evaluation of haemodynamics, functional status, and quality of life after radiofrequency catheter ablation of long-standing persistent atrial fibrillation.前瞻性评估射频导管消融治疗慢性持续性心房颤动后的血液动力学、功能状态和生活质量。
Europace. 2014 Jan;16(1):15-25. doi: 10.1093/europace/eut161. Epub 2013 Jul 12.
引用本文的文献
1
Impact of Obesity on Atrial Electrophysiological Substrate.肥胖对心房电生理基质的影响。
J Cardiovasc Dev Dis. 2023 Aug 8;10(8):342. doi: 10.3390/jcdd10080342.
本文引用的文献
1
Influence of body mass index on quality of life in atrial fibrillation patients undergoing catheter ablation.体重指数对接受导管消融的心房颤动患者生活质量的影响。
Heart Rhythm. 2011 Dec;8(12):1847-52. doi: 10.1016/j.hrthm.2011.07.005. Epub 2011 Jul 6.
2
Development and validation of the Atrial Fibrillation Effect on QualiTy-of-Life (AFEQT) Questionnaire in patients with atrial fibrillation.心房颤动对生活质量影响问卷（AFEQT）在心房颤动患者中的开发和验证。
Circ Arrhythm Electrophysiol. 2011 Feb;4(1):15-25. doi: 10.1161/CIRCEP.110.958033. Epub 2010 Dec 15.
3
Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs.与抗心律失常药物相比，经导管射频消融治疗阵发性心房颤动患者的症状及生活质量改善情况。
Circ Cardiovasc Qual Outcomes. 2010 Nov;3(6):615-23. doi: 10.1161/CIRCOUTCOMES.110.957563. Epub 2010 Oct 12.
4
Influence of obesity on outcomes in atrial fibrillation: yet another obesity paradox.肥胖对房颤结局的影响：又一个肥胖悖论。
Am J Med. 2010 Jul;123(7):646-51. doi: 10.1016/j.amjmed.2009.11.026.
5
Long-term quality of life after ablation of atrial fibrillation the impact of recurrence, symptom relief, and placebo effect.房颤消融术后的长期生活质量：复发、症状缓解和安慰剂效应的影响。
J Am Coll Cardiol. 2010 May 25;55(21):2308-16. doi: 10.1016/j.jacc.2010.01.040.
6
Prevalence and trends in obesity among US adults, 1999-2008.美国成年人肥胖率的流行趋势及变化，1999-2008 年。
JAMA. 2010 Jan 20;303(3):235-41. doi: 10.1001/jama.2009.2014. Epub 2010 Jan 13.
7
The obesity paradox and outcome in heart failure: is excess bodyweight truly protective?肥胖悖论与心力衰竭的预后：超重真的具有保护作用吗？
Future Cardiol. 2010 Jan;6(1):1-6. doi: 10.2217/fca.09.158.
8
A prospective study evaluating the role of obesity and obstructive sleep apnea for outcomes after catheter ablation of atrial fibrillation.一项前瞻性研究评估了肥胖和阻塞性睡眠呼吸暂停对心房颤动导管消融术后结局的影响。
J Cardiovasc Electrophysiol. 2010 May;21(5):521-5. doi: 10.1111/j.1540-8167.2009.01653.x. Epub 2009 Nov 17.
9
The obesity paradox in patients with peripheral arterial disease.外周动脉疾病患者中的肥胖悖论
Chest. 2008 Nov;134(5):925-930. doi: 10.1378/chest.08-0418. Epub 2008 Jul 18.
10
Catheter ablation for atrial fibrillation in patients with obesity.肥胖患者心房颤动的导管消融治疗
Circulation. 2008 May 20;117(20):2583-90. doi: 10.1161/CIRCULATIONAHA.107.716712. Epub 2008 May 12.
Zotero 插件